2026 Q3 Portfolio Activity
In 2026 Q3, Eagle Health Investments LP maintained a portfolio of 32 distinct positions. The most significant new addition was UNITED THERAPEUTICS CORP DEL, now representing 7.10% of the total fund value. They heavily accumulated shares in INTUITIVE SURGICAL INC, increasing the position by 2372.6%. Conversely, Eagle Health Investments LP completely exited their position in BIOMARIN PHARMACEUTICAL INC.
Position History
hover any row below to update
Loading…
Total Positions
32
Quarter
2026 Q3
Top Holding
ARGX (12.1%)
Top 10 Concentration
69.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-32 of 32
Eagle Health Investments LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ARGX
ARGENX SE
|
Healthcare | 12.07% | 11.75% |
#1
Prev: #1
|
6.5 |
—
|
176 | 0.2% |
P
S
|
76,593 | $73,445,794 |
$378.37
+151.4%
|
2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
GH
GUARDANT HEALTH...
|
Healthcare | 8.81% | 7.48% |
#2
1
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
300,685 | $53,630,177 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ICLR
ICON PUB LTD CO
|
Healthcare | 7.40% | 8.87% |
#3
1
Prev: #2
|
4.5 |
—
|
-43,333 | -14.1% |
P
S
|
264,810 | $45,015,052 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 7.25% | 0.29% |
#4
21
Prev: #25
|
6.4 |
—
|
104,156 | 2372.6% |
P
S
|
108,546 | $44,138,060 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 7.10% | — |
#5
Prev: #—
|
6.8 |
—
|
79,678 | — |
NEW
|
79,678 | $43,176,711 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INSM
INSMED INC
|
Healthcare | 6.73% | 6.79% |
#6
2
Prev: #4
|
3.2 |
—
|
-25,428 | -6.6% |
P
S
|
358,702 | $40,942,246 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 5.75% | 5.05% |
#7
1
Prev: #8
|
3.3 |
—
|
no change | no change |
P
S
|
248,322 | $34,986,087 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 5.28% | — |
#8
Prev: #—
|
5.6 |
—
|
879,191 | — |
NEW
|
879,191 | $32,152,015 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 4.46% | 5.06% |
#9
2
Prev: #7
|
2.3 |
—
|
6,255 | 1.1% |
P
S
|
561,527 | $27,132,985 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 4.44% | 4.69% |
#10
1
Prev: #11
|
3.8 |
—
|
12,471 | 11.7% |
P
S
|
118,629 | $27,027,245 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GH
PUT
GUARDANT HEALTH...
|
PUT Option | 4.41% | — |
#11
Prev: #—
|
5.3 |
—
|
150,300 | — |
NEW
|
150,300 | $26,807,508 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 4.21% | 4.83% |
#12
2
Prev: #10
|
2.7 |
—
|
no change | no change |
P
S
|
2,060,427 | $25,631,712 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 4.06% | 3.74% |
#13
1
Prev: #12
|
2.6 |
—
|
no change | no change |
P
S
|
120,346 | $24,702,220 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FTRE
FORTREA HLDGS I...
|
Healthcare | 3.87% | 3.41% |
#14
1
Prev: #13
|
2.5 |
—
|
no change | no change |
P
S
|
1,181,274 | $23,566,416 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 3.29% | 2.61% |
#15
1
Prev: #16
|
3.8 |
—
|
89,950 | 24.4% |
P
S
|
459,114 | $20,040,326 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 2.19% | 3.16% |
#16
2
Prev: #14
|
0.9 |
—
|
-46,880 | -28.2% |
P
S
|
119,268 | $13,332,970 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.98% | 2.58% |
#17
Prev: #17
|
1.8 |
—
|
no change | no change |
P
S
|
297,302 | $12,046,677 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.97% | 2.64% |
#18
3
Prev: #15
|
1.8 |
—
|
no change | no change |
P
S
|
65,051 | $11,994,754 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.90% | 2.12% |
#19
1
Prev: #20
|
1.8 |
—
|
no change | no change |
P
S
|
131,344 | $11,564,839 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 1.58% | — |
#20
Prev: #—
|
4.1 |
—
|
724,787 | — |
NEW
|
724,787 | $9,596,180 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.59% | 0.72% |
#21
1
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
235,093 | $3,603,976 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 0.43% | — |
#22
Prev: #—
|
3.7 |
—
|
154,493 | — |
NEW
|
154,493 | $2,612,477 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.23% | 0.24% |
#23
3
Prev: #26
|
1.1 |
—
|
no change | no change |
P
S
|
46,300 | $1,402,427 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PCSC
PERCEPTIVE CAP ...
|
Financial Services | 0.00% | 0.07% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-37,686 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-1,994 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NTRA
NATERA INC
|
Healthcare | 0.00% | 0.71% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-15,847 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ATAI
ATAIBECKLEY INC
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-1,709,359 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 0.00% | 2.46% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-256,269 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.00% | 2.56% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-194,577 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 4.89% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-884,121 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ILMN
ILLUMINA INC
|
Healthcare | 0.00% | 5.46% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-187,413 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.00% | 5.92% |
Sold All 😨
(Was: #5) |
0.0 |
—
|
-624,676 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-32 of 32 holdings